The text messages sent by Metrolink train engineer, Robert Sanchez, were made public by the NTSB this week. Records show that Sanchez was texting a friend only 22 seconds before the deadly impact which killed 25 people, including Sanchez. The accident also injured another 101 people on board and caused over $10 million in damages, according to a report by federal investigators.
In addition to the messages sent that day ...
continue reading...Raptiva is an injectable drug used for the treatment of psoriasis. It has been discovered to cause a serious brain infection called progressive multifocal leukoencephalopathy, or PML. The FDA has confirmed at least three cases of patients who died from PML after using Raptiva more than three years. According to the National Institutes of Health, PML usually lasts for months, 80 percent die within the first six months, and those who survive can be left with severe neurological disabilities.
In October ...
continue reading...FEBRUARY 17, 2009 – Requip, a drug designed to treat Parkinson’s Disease and also sold as a treatment for Restless Leg Syndrome, has been linked to compulsive behaviors, including gambling. This is similar to the effects of the drug Mirapex, another dopamine agonist for treating Parkinson’s. As early as 2003, these drugs were known to cause pathological gambling and other compulsive behavior.
continue reading...By Josh Goldstein and Joseph N. DiStefano
August 20, 2005
The Philadelphia Inquirer
It was just the first of more than 4,200 lawsuits against Merck & Co. Inc. over its Vioxx painkiller, but news of yesterday’s $253.4 million verdict in Texas against the drugmaker surged through the legal profession and Wall Street.
In New York City, where Alise Reicin, Merck’s vice president of clinical research, was being deposed by lawyers representing plaintiffs in other Vioxx cases, the verdict caused a stir.
Shortly after learning the ...
continue reading...By Maria Vogel-Short
New Jersey Law Journal
February 13, 2008
Plaintiffs in New Jersey and six other states who claim the antibiotic Ketek caused liver disease are getting a booster shot from a congressional inquiry into the clinical trials that led to FDA approval.
On Tuesday, witnesses at a hearing before the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations testified that Ketek’s trials were flawed and that the company had knowledge of flawed data even before FDA approval.
More than pending ...
continue reading...FOR IMMEDIATE RELEASE:
CONTACT: Attorney Ramon R. Lopez and/or Attorney Jason E. Ochs
Telephone: 949-737-1501
Fax: 949-737-1504
Email: rlopez@lopezmchugh.com, jochs@lopezmchugh.com
CEDARS-SINAI PATIENTS SUE BECAUSE OF FATAL DISEASE.
Los Angeles, California, January 16, 2008 – On Friday, January 11, 2008, 63-year-old Priscilla Geffen and 60-year-old Michael Gleaton filed nearly identical lawsuits alleging that they contracted a rare, terminal disease known as nephrogenic systemic fibrosis after undergoing routine MRI’s with gadolinium-contrast dye at the S. Mark Taper Imaging Center ...
